The significance of detecting WT1 expression in childhood acute leukemias

Pediatric Hematology and Oncology

Volumn 27, Issue 8, 2010, Pages 581-591

  Hu, Shao Yan ^a   Gu, Wei Ying ^b   Chen, Zi Xing ^c   Wang, Xu Li ^e   Cen, Jian Nong ^c   He, Hai Long ^a   Chai, Yi Huan ^a   Chen, Chien Shing ^d  

^a CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

^d LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Children's Hospital of Soochow   (China)

Author keywords

Acute leukemia; Children; Minimal residual disease (MRD); RQ PCR (real time quantitative RT PCR); WT1 (Wilms' tumor gene 1)

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; HARRINGTONINE; METHOTREXATE; RETINOIC ACID; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM LEUKEMIA; CHILD; CHILDHOOD LEUKEMIA; CHINESE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC VALUE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PRESCHOOL CHILD; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TREATMENT RESPONSE;

CHILD; CHILD, PRESCHOOL; CYTOGENETIC ANALYSIS; FEMALE; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; NEOPLASM, RESIDUAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WT1 PROTEINS;

EID: 77958037297     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880011003762994     Document Type: Article

References (18)

1. Oji Y, Miyoshi S, Maeda H, et al. Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer. 2002;100:297-303.
2. Oji Y, Nakamori S, Fujikawa M, et al. Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma. Cancer Sci. 2004;95:583-587. (Pubitemid 39089639)
3. Cilloni D, Saglio G. WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome. Acta Haematol. 2004;112:79-84.
4. Boublikova L, Kalinova M, Ryan J, et al. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. Leukemia. 2006;20:254-263.
5. Cilloni D, Gottardi E, De Micheli D, et al. Quantitative assessment of WT1 expression by real- time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia. 2002;16:2115-2121.
6. Trka J, Kalinova M, Hrusak O, et al. Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry. Leukemia. 2002;16:1381-1389.
7. Kletzel M, Olzewski M, Huang W, Chou PM. Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia. Pediatr Dev Pathol. 2002;5:269-275.
8. Magyarosy E, Varga N, Tiḿar J, Ŕaśo E. Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience. Pediatr Hematol Oncol. 2003;20:65-74.
9. Barragan E, Cervera J, Bolufer P, et al. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica. 2004;89:926-933.
10. Ostergaard M, Olesen LH, Hasle H, et al. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients-results from a single-centre study. Br J Haematol. 2004;125:590-600.
11. Ogawa H, Tamaki H, Ikegame K, et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood. 2003;101:1698-1704.
12. Garg M, Moore H, Tobal K, Liu Yin JA. Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia. Br J Haematol. 2003;123:49-59.
13. Schmid D, Heinze G, Linnerth B, et al. Prognostic significance ofWT1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia. 1997;11:639-643.
14. Gaiger A, Linnerth B, Mann G, et al.Wilms' tumour gene (WT1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol. Eur J Haematol. 1999;63:86-93.
15. Gu WY, Chen ZX, Hu SY, et al. Changes in expression of WT1 isoforms during induced differentiation of the NB4 cell line. Haematologica. 2005;90:403-405.
16. He J, Chen ZX, Xue YQ, et al. Detection of fusion genes results from chromosome abnormalities in childhood acute lymphoblastic leukemia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005;22:551-553.
17. [Suggestion of diagnosis and treatment of acute lymphoblastic leukemia in childhood (the 3rd revised version)] Subspecialty Group of Hematology Diseases, the Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. Zhonghua Er Ke Za Zhi. 2006;44:392-395.
18. [Suggestion of diagnosis and treatment of acute myelocytic leukemia in childhood] Subspecialty Group of Hematology Disease, The Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. Zhonghua Er Ke Za Zhi. 2006;44:877-878.